Clinical Trial of the Efficacy and Safety of Raphamin in Combined Treatment of Community-acquired Pneumonia

Clinical trial NCT06263881 · COMPLETED

Trial details

NCT number: NCT06263881
Sponsor: Materia Medica Holding
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Community-acquired Pneumonia Pneumonia

Start date: 2023-12-01
Primary completion: 2025-03-19
Enrollment: 370

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.